Louis Denis

Dr. Denis was appointed Chief Medical Officer in September 2021. Dr. Denis is a medical oncologist and brings to Verastem more than 25 years of academic and industry experience in clinical cancer drug development. Prior to joining Verastem, Dr. Denis was the Chief Medical Officer of Asana BioSciences where he provided strategic direction as well as medical and safety oversight to Asana’s portfolio of oncology and immunology assets. Previously, Dr. Denis held various leadership roles in Oncology clinical development and medical affairs at Boehringer Ingelheim and Pfizer. Dr. Denis received his MD from Vrije Universiteit Brussel Medical School, Belgium, and did his post-doctoral fellowships in Internal Medicine/Medical Oncology at Middelheim Hospital, Antwerp; the Rotterdam Cancer Institute, The Netherlands; and the Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, Texas.